Metraipolis › archive › dc_25e79cccf2bb

Reconsidering Digoxin in Atrial Fibrillation: From Historical Controversy to Physiologically Guided and Personalized Rate Control — Europe PMC PMID:41463106

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41463106
DOI: 10.3390/biomedicines13123098
License (as archived): solo-consultazione
Archived: 2026-11-07T14:46:03.808Z
SHA-256 of the archived text: cf9c420d85af0158d0d55c148427c87be3d4402cf6a1c7f2917644a725e8f3f0
Stable URL of this page: https://metraipolis.com/documento/dc_25e79cccf2bb

How to cite

Reconsidering Digoxin in Atrial Fibrillation: From Historical Controversy to Physiologically Guided and Personalized Rate Control — Europe PMC PMID:41463106 — Europe PMC (en), https://europepmc.org/article/MED/41463106 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_25e79cccf2bb (Metraipolis archive dc_25e79cccf2bb, sha256 cf9c420d85af0158d0d55c148427c87be3d4402cf6a1c7f2917644a725e8f3f0)

BibTeX

@misc{dc25e79cccf2bb,
  title = {Reconsidering Digoxin in Atrial Fibrillation: From Historical Controversy to Physiologically Guided and Personalized Rate Control — Europe PMC PMID:41463106},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41463106},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_25e79cccf2bb; sha256 cf9c420d85af0158d0d55c148427c87be3d4402cf6a1c7f2917644a725e8f3f0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41463106. Agents can read the archived copy with the MCP tool read_document.